Northern Trust’s Mateon Therapeutics MATN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-25,499
Closed -$16K – 4230
2016
Q3
$16K Hold
25,499
– – ﹤0.01% 4119
2016
Q2
$17K Buy
+25,499
New +$18.1K ﹤0.01% 4131

Other funds holding MATN

Northern Trust's MATN Position: Q4 2016 in Review

Northern Trust sold out of Mateon Therapeutics (MATN) in Q4 2016, closing a stake of 25,499 shares — an estimated $16K sold.

Northern Trust first reported a position in MATN in Q2 2016 and held it in 2 quarters. The position peaked at $17K in Q2 2016. 1 fund tracked by Wall St. Rank holds MATN as of Q4 2016.

  • Northern Trust reported no remaining Mateon Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Northern Trust sold 25,499 Mateon Therapeutics shares in Q4 2016, an estimated $16K.
  • Northern Trust first reported a position in Mateon Therapeutics in Q2 2016 and held it in 2 quarters.
  • Northern Trust's Mateon Therapeutics position peaked at $17K in Q2 2016.
  • 1 fund tracked by Wall St. Rank held Mateon Therapeutics as of Q4 2016.

Based on Northern Trust's 13F filing for Q4 2016, filed 13 Feb 2017.